These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37176165)

  • 41. GABRB3-related epilepsy: novel variants, clinical features and therapeutic implications.
    Yang Y; Zeng Q; Cheng M; Niu X; Xiangwei W; Gong P; Li W; Ma J; Zhang X; Yang X; Yang Z; Sun D; Zhou S; Liao J; Jiang Y; Zhang Y
    J Neurol; 2022 May; 269(5):2649-2665. PubMed ID: 34698933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of GABAA Receptor Gene with Epilepsy Syndromes.
    Bhat MA; Guru SA; Mir R; Waza AA; Zuberi M; Sumi MP; Bodeliwala S; Puri V; Saxena A
    J Mol Neurosci; 2018 Jun; 65(2):141-153. PubMed ID: 29785705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. All children who experience epileptic falls do not necessarily have Lennox-Gastaut syndrome... but many do.
    Arzimanoglou A; Resnick T
    Epileptic Disord; 2011 May; 13 Suppl 1():S3-13. PubMed ID: 21669558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ; Chin RFM
    Expert Rev Neurother; 2024 Mar; 24(3):235-249. PubMed ID: 38315124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures.
    Eschbach K; Moss A; Joshi C; Angione K; Smith G; Dempsey A; Juarez-Colunga E; Demarest ST
    Epilepsy Res; 2018 Nov; 147():95-101. PubMed ID: 30286391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and genetic study of developmental and epileptic encephalopathy in Argentinean pediatric patients.
    Juanes M; Loos M; Reyes G; Veneruzzo G; García FM; Aschettino G; Calligaris S; Martín ME; Foncuberta ME; Alonso CN; Caraballo RH
    Medicina (B Aires); 2022; 82(6):856-865. PubMed ID: 36571524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lennox-Gastaut syndrome: a consensus approach to differential diagnosis.
    Bourgeois BF; Douglass LM; Sankar R
    Epilepsia; 2014 Sep; 55 Suppl 4():4-9. PubMed ID: 25284032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age at onset in patients with Lennox-Gastaut syndrome: Correlations with clinical manifestations.
    Asadi-Pooya AA; Farazdaghi M
    J Clin Neurosci; 2022 Jun; 100():138-142. PubMed ID: 35468350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of Lennox-Gastaut syndrome and strategies for early recognition.
    Pujar S; Cross JH
    Expert Rev Neurother; 2024 Apr; 24(4):383-389. PubMed ID: 38415629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome.
    Montouris GD; Wheless JW; Glauser TA
    Epilepsia; 2014 Sep; 55 Suppl 4():10-20. PubMed ID: 25284033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
    Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
    Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does response to vagus nerve stimulation for drug-resistant epilepsy differ in patients with and without Lennox-Gastaut syndrome?
    Dibué M; Greco T; Spoor JKH; Senft C; Kamp MA
    Brain Behav; 2023 Aug; 13(8):e3025. PubMed ID: 37386739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Why the diagnosis of Lennox-Gastaut syndrome is a rare one?].
    Belousova ED; Gorchanova ZK; Dorofeeva MY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11. Vyp. 2):41-47. PubMed ID: 32207730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epilepsy Surgery is a Viable Treatment for Lennox Gastaut Syndrome.
    Keator CG
    Semin Pediatr Neurol; 2021 Jul; 38():100894. PubMed ID: 34183143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early Diagnosis and Treatment of Lennox-Gastaut Syndrome.
    Resnick T; Sheth RD
    J Child Neurol; 2017 Oct; 32(11):947-955. PubMed ID: 28689466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.
    Alonso-Singer P; Aguilar-Amat Prior MJ; Oliva-Navarro J; Massot-Tarrús A; Giráldez BG; Bermejo P; DeToledo-Heras M; Aledo-Serrano Á; Martínez-Cayuelas E; Tirado-Requero P; Velázquez-Fragua R; López-Sobrino G; Ojeda J
    Epilepsy Behav; 2022 Sep; 134():108836. PubMed ID: 35870432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive and functional status in late-onset Lennox-Gastaut syndrome: Variation on a classic phenotype.
    Chourasia N; Maheshwari A; Kalamangalam G
    Epilepsy Behav; 2020 Jan; 102():106660. PubMed ID: 31770718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered thalamic GABAA-receptor subunit expression in the stargazer mouse model of absence epilepsy.
    Seo S; Leitch B
    Epilepsia; 2014 Feb; 55(2):224-32. PubMed ID: 24417662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel GABRB3 variant in Dravet syndrome: Case report and literature review.
    Pavone P; Pappalardo XG; Marino SD; Sciuto L; Corsello G; Ruggieri M; Parano E; Piccione M; Falsaperla R
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1461. PubMed ID: 32945607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.